Sam Hume leads the CDISC Data Science team who develops tools and standards that support clinical and translational research. Sam directs delivery of the CDISC Library, leads the Data Exchange Standards team, and serves as a leader of CORE. Additionally, he oversees the CDISC Open-Source Alliance (COSA), which supports CDISC-related open-source software projects. Sam has 30 years’ experience working in clinical research informatics and has held several senior-level technology positions in the biopharmaceutical industry. He holds a doctorate in Information Systems.

Mohammad Alajarmeh is an accomplished non-practicing physician in clinical research with experience in clinical operations. He had the opportunity to collaborate on various projects across all phases of clinical drug development.

Battle-ready project oversight aficionado, with a proven history of working in both the Pharmaceutical and Medical Device landscapes. Innovator, trail blazer and process improvement advocate and guru. Skilled in Electronic Data Capture (EDC), Good Laboratory Practice (GLP), Medical Devices, Good Clinical Practice (GCP), and Clinical Trial Management System (CTMS). VERY detail-oriented, loves to do things outside-the-box, run on unpaved trails, and flip burgers differently from everybody else. Motto: "Comfort zone... remind me what this is again?"

Satish Dachepally is an Executive Director at Incyte Corporation focusing on Clinical Data Management areas. Satish has over 20 years of success in overseeing the collection, analysis, and reporting of clinical trial data.  He is adept at implementing industry standards and best practices, including CDISC SDTM and CDASH to ensure data integrity, compliance, and streamlined processes.  He is dedicated leader passionate about advancing clinical research through robust data management practices.  He made significant contributions to successful approval of multiple marketed drugs across diverse indications.  Satish earned a Master of Science degree from United Kingdom.

Narayan has and ten (10)+ years of award-winning and progressive experience delivering the highest standards of clinical data management at Bayer and Bristol Myers Squibb (BMS). Bayer Gold Award 2017, Bronze Award 2016, and Pinnacle Award 2015; BMS Performance Award. In-depth knowledge of all aspects of clinical data management, reporting, reconciliation, study reviews, and standards development that drive pharmaceutical businesses forward. 

Joshua Cox has been honing his data management expertise in the drug development industry for nearly 20 years.  After breaking into the industry and gaining exposure to diverse therapeutic areas and development approaches with a CRO, Joshua has focused the last 15-years in sponsor driven early phase oncology.  He has enjoyed opportunities with bio-tech start-ups as well as established big pharma companies, each engagement adding valuable knowledge and experience to his skillset.  Joshua has led the development of data management departments by conceiving and implementing fit for purpose and results-driven technologies and processes always with an eye toward innovation and efficiency.  Now pursuing leadership opportunities outside the confines of traditional data management, Joshua is eager and excited to be a part of teams pursuing novel solutions to known challenges as well as employing cutting edge strategies and technologies to elevate the already high standards we expect and ultimately get the best medicines to the patients in need.

Chris has ~25 years industry experience, ranging from working in the CRO space, as well as for big Pharma to small Biotechs. He is currently at Moderna, as the Director, Clinical Data Management, where he manages multiple direct reports and oversees the Oncology portfolio.  Chris has worked across a variety of therapeutic areas, including Oncology, Virology, Immunology, Cardiovascular, Women’s Health, Neurology, and Metabolic Disorders.  He has  worked on studies ranging from both Phase 1 Healthy Volunteer and Phase 1 Oncology through Phase 3 registrational trials.  Chris is honored to have worked on multiple treatments that made it to market and significantly improved both the quantity and quality of life of the individuals needing treatment.

Chris attended Montclair State University (NJ), where he received both his Bachelor’s and Master of Science degrees in Biology.  He also spent more than 20 years there as a part-time Adjunct Biology Professor.

Away from work, Chris enjoys traveling, hiking, fishing, birdwatching, nature photography, movies, Broadway shows, concerts, and spending time with his family.

Devdatt (Dev) Patel is a Director of Clinical Data Management overseeing late-stage programs at Seagen. He has 20 years of experience in the CDM domain. Prior to his work at Seagen, Devdatt was an Associate Director, leading multiple compounds in various phases (e.g., Ph I-IV) of Clinical Trials. In his early career days, he also has diverse experience in the SAS programming field; from EDC build, SAS listings and SDTM programming. Dev has a Bachelor in Arts and Sciences from Rutgers University.

Noopur’s motivation stems from her desire to help mitigate treatment access challenges seen across indications. She is focused on strategic patient-centered drug development that bridges scientific gaps and cuts through red tape across the drug supply chain. She is determined to increase access to treatments to help fulfill current unmet needs. Her approach stems from the patient journey, ensuring it is integrated throughout the drug development life cycle. In her role as Director of Medical Affairs, Noopur nurtures Xentria’s key relationships with patient experts, key opinion leaders and clinical investigators.

Prior to her role at Xentria, Noopur was the Research Director at the Foundation for Sarcoidosis Research where she played a key role in the development and execution of the organization’s scientific research agenda. Noopur has also worked as Clinical Site Manager for Synexus Clinical Research in Chicago, where she was responsible for operationalizing clinical trials. Noopur held several roles at Lurie’s Children’s Hospital Chicago where she managed over 25 industry-sponsored trials. She has also been an active participant in the Therapeutics Development Network with the Cystic Fibrosis Foundation. Noopur earned a B.S.in Kinesiology from the University of Michigan.

Dawn has over 20 years of experience in the pharmaceutical industry. She has worked within every level of clinical data management, from Data Coordinator to Senior Director where she participated in or had oversight for more than 250 clinical trials. During her time in the industry, she has provided consultation to organizations on clinical trial conduct, best practices in Data Management and data capture as well as developed standardized libraries and templates to support the adoption of CDISC standards. She is an active member of SCDM as a GCDMP SME, course designer and webinar presenter as well as Co-Chair of the annual conference (2018-2021) and serves on the SCDM Board of Trustees. Dawn is involved as a member of the CDISC-CDASH core team, Diabetes sub-team, CDASH CFAST Expanded Leadership Team and former Co-Chair of the CRF Library project. Dawn currently holds the position of Vice President, BD Operations, where she supports business development as a Clinical Subject Matter Expert for both software and data services as well as overseeing the Proposals and Solution Consulting departments.

Wendy has 25+ years experience in the life sciences industry with a career spanning academic research, preclinical drug discovery, and clinical trials, culminating in a focus and passion for delivering technology solutions that help bring treatments to patients faster.  Wendy is currently part of the product strategy leadership team for IQVIA Clinical Data Analytics Suite (CDAS), providing both SaaS solutions for the market as well as IQVIA’s internal CRO needs.  As part of the CDAS team, Wendy is responsible for strategy, product management leadership, and Go to Market activities.

Sverre Bengtsson started in the clinical trials industry over 30 years ago. He started as a statistician/statistical programmer, later into data management and since over 20 years into business development. He has been working in both CRO’s as well as in clinical trials technology companies, including the global first ePRO company. Sverre is very interested in making clinical trials efficient, in both study design but also in the processes and technologies used. Sverre co-founded Viedoc Technologies 19 years ago and is responsible for some of the major accounts but also the vision around the company. He’s on the board of both some industry organisations and in clinical technology companies.

Innovative leader with 20 years of clinical research and healthcare experience, specializing in acquisition, management, and transformation of clinical biospecimen and digital health assessment data. Collaborative creator of tech-enabled solutions for the pharmaceutical industry. Accomplished, analytical director possessing strong interpersonal and communication skills with experience in managing multi-functional teams at both a strategic and tactical level. Key strengths include driving transformational change, strategic planning and execution, spearheading business process improvement initiatives, and building high-performing organizations. Built and introduced countless strategies within R&D to achieve efficiencies and resolve process and application gaps. Experienced in operations oversight and guidance, including resource and financial projections and prioritization.